Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 99

1.

Sensitive quantitative assay for point mutations in the rat H-ras gene based on single nucleotide primer extension.

Yano Y, Yano T, Kinoshita A, Matoba A, Hasuma T, Wanibuchi H, Morimura K, Otani S, Fukushima S.

Exp Ther Med. 2010 Jul;1(4):657-661. Epub 2010 Jul 1.

2.

Role of proto-oncogene activation in carcinogenesis.

Anderson MW, Reynolds SH, You M, Maronpot RM.

Environ Health Perspect. 1992 Nov;98:13-24. Review.

3.

A universal method for the mutational analysis of K-ras and p53 gene in non-small-cell lung cancer using formalin-fixed paraffin-embedded tissue.

Sarkar FH, Valdivieso M, Borders J, Yao KL, Raval MM, Madan SK, Sreepathi P, Shimoyama R, Steiger Z, Visscher DW, et al.

Diagn Mol Pathol. 1995 Dec;4(4):266-73.

PMID:
8634783
4.

Are tumor incidence rates from chronic bioassays telling us what we need to know about carcinogens?

Gaylor DW.

Regul Toxicol Pharmacol. 2005 Mar;41(2):128-33. Epub 2004 Dec 19.

PMID:
15698536
5.

Carcinogen-induced impairment of enzymes for replicative fidelity of DNA and the initiation of tumours.

Bignold LP.

Carcinogenesis. 2004 Mar;25(3):299-307. Epub 2003 Nov 6.

PMID:
14604890
6.

Mutations in the ras proto-oncogene: clues to etiology and molecular pathogenesis of mouse liver tumors.

Maronpot RR, Fox T, Malarkey DE, Goldsworthy TL.

Toxicology. 1995 Aug 25;101(3):125-56. Review.

PMID:
7676462
7.
8.

K-ras point mutation detection in lung cancer: comparison of two approaches to somatic mutation detection using ARMS allele-specific amplification.

Clayton SJ, Scott FM, Walker J, Callaghan K, Haque K, Liloglou T, Xinarianos G, Shawcross S, Ceuppens P, Field JK, Fox JC.

Clin Chem. 2000 Dec;46(12):1929-38.

9.

Detection of rare K-ras codon 12 mutations using allele-specific competitive blocker PCR.

McKinzie PB, Parsons BL.

Mutat Res. 2002 May 27;517(1-2):209-20.

PMID:
12034322
11.
12.

Current and emerging challenges in toxicopathology: carcinogenic threshold of phenobarbital and proof of arsenic carcinogenicity using rat medium-term bioassays for carcinogens.

Fukushima S, Morimura K, Wanibuchi H, Kinoshita A, Salim EI.

Toxicol Appl Pharmacol. 2005 Sep 1;207(2 Suppl):225-9. Review.

PMID:
15993454
13.
15.

Environmental and chemical carcinogenesis.

Wogan GN, Hecht SS, Felton JS, Conney AH, Loeb LA.

Semin Cancer Biol. 2004 Dec;14(6):473-86. Review.

PMID:
15489140
16.
17.

Induction of mutations in Ki-ras and INK4a in liver tumors of mice exposed in utero to 3-methylcholanthrene.

Gressani KM, Rollins LA, Leone-Kabler S, Cline JM, Miller MS.

Carcinogenesis. 1998 Jun;19(6):1045-52.

PMID:
9667743
18.

The results of assays in Drosophila as indicators of exposure to carcinogens.

Vogel EW, Graf U, Frei HJ, Nivard MM.

IARC Sci Publ. 1999;(146):427-70. Review.

PMID:
10353398
19.

Mutation profile of the p53, fhit, p16INK4a/p19ARF and H-ras genes in Indian breast carcinomas.

Kannan K, Krishnamurthy J, Feng J, Nakajima T, Tsuchida N, Shanmugam G.

Int J Oncol. 2000 Nov;17(5):1031-5.

PMID:
11029509
20.

Qualitative and quantitative approaches in the dose-response assessment of genotoxic carcinogens.

Fukushima S, Gi M, Kakehashi A, Wanibuchi H, Matsumoto M.

Mutagenesis. 2016 May;31(3):341-6. doi: 10.1093/mutage/gev049. Epub 2015 Jul 7.

PMID:
26152227

Supplemental Content

Support Center